SLC5A2 and heart failure: By analyzing the results of burst keywords such as “heart failure,” “ejection fraction,” “mortality,” and “mechanism,” as well as the keyword co-occurrence clusters terms such as clinical trials, mechanisms, and therapy, we revealed that recent clinical trials of SGLT2 inhibitors have mainly focused on cardiovascular outcomes and mortality, especially in heart failure.